Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-18

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (AMERISOURCE BERGEN)

View source ↗

Summary

The FDA approved a supplemental application for naloxone hydrochloride from AmerisourceBergen, enabling a generic naloxone product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)